{"entity":{"id":"robert-figlin","kind":"person","name":"Robert Figlin","aka":[],"tldr":"Medical oncologist who has led Cedars-Sinai Cancer in Los Angeles as Interim Director since March 2025.","summary":"Robert Figlin, MD, is Interim Director of Cedars-Sinai Cancer, the cancer programme of Cedars-Sinai in Los Angeles. He was Deputy Director of the cancer centre and took over as Interim Director on 28 February 2025 when Dan Theodorescu stepped down, with Cristina Ferrone as Interim Co-Director for Cancer Clinical Services and Ze'ev Ronai as Interim Cancer Scientific Director. In a March 2026 Becker's Healthcare podcast he was still described as Interim Director, speaking on expanding access to cancer care and bridging discovery with clinical practice.","asOf":"2026-09-10","links":[{"label":"Source: Cedars-Sinai newsroom, director stepping down (Feb 2025)","url":"https://www.cedars-sinai.org/newsroom/cedars-sinai-cancer-director-stepping-down/"}],"tags":["leadership","clinician-scientist","cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["cedars-sinai-cancer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["international-journal-of-cancer","the-oncologist"],"dependsOn":[],"notes":[],"role":"Interim Director of Cedars-Sinai Cancer","institutionId":"cedars-sinai-cancer","specialisms":["Medical oncology","Cancer centre leadership","Translational research"],"profiles":[{"label":"Institution newsroom (March 2026)","url":"https://www.cedars-sinai.org/newsroom/beckers-healthcare-podcast-expanding-access-translational-research-and-the-future-of-cancer-care/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Figlin+RA%5BAuthor%5D"}],"papers":[{"title":"Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma","journal":"The Oncologist","year":2017,"doi":"10.1634/theoncologist.2016-0197"},{"title":"Novel Agents and Approaches for Advanced Renal Cell Carcinoma","journal":"Journal of Urology","year":2012,"doi":"10.1016/j.juro.2012.04.108"},{"title":"Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors","journal":"International Journal of Cancer","year":2013,"doi":"10.1002/ijc.28023"}]},"route":"/people/robert-figlin/","neighbours":{"institution":[{"id":"cedars-sinai-cancer","kind":"institution","name":"Cedars-Sinai Cancer","route":"/institutions/cedars-sinai-cancer/"}],"journal":[{"id":"international-journal-of-cancer","kind":"journal","name":"International journal of cancer","route":"/journals/international-journal-of-cancer/"},{"id":"the-oncologist","kind":"journal","name":"The oncologist","route":"/journals/the-oncologist/"}]}}